He Zhuo bone (Zometa) can be effective in preventing pre-menopausal breast cancer patients because they have received adjuvant hormonal therapy for bo

Breast cancer patients receiving postoperative adjuvant therapy, the treatment often causes bone loss caused by complications of bone. And supporting menopausal hormone replacement therapy for breast cancer patients before, is often important after chemotherapy treatment, one study shows that the longer the use of hormone therapy, bone density decrease in more serious cases. Every six months if they can give him bone zhuo 4-8 mg, with the rules of bone mineral density tracking, would be effective in the prevention of hormone therapy due to bone loss caused by.